Abstract:Somatic mutations in spliceosome proteins lead to dysregulated RNA splicing and are observed in a variety of cancers. These genetic aberrations may offer a potential intervention point for targeted therapeutics. SF3B1, part of the U2 small nuclear RNP (snRNP), is targeted by splicing modulators, including E7107, the first to enter clinical trials, and, more recently, H3B-8800. Modulating splicing represents a first-in-class opportunity in drug discovery, and elucidating the structural basis for the mode of action opens up new possibilities for structure-based drug design. Here, we present the cryogenic electron microscopy (cryo-EM) structure of the SF3b subcomplex (SF3B1, SF3B3, PHF5A, and SF3B5) bound to E7107 at 3.95 angstrom. This structure shows that E7107 binds in the branch point adenosine-binding pocket, forming close contacts with key residues that confer resistance upon mutation: SF3B1(R1074H) and PHF5A(Y36C). The structure suggests a model in which splicing modulators interfere with branch point adenosine recognition and supports a substrate competitive mechanism of action (MOA). Using several related chemical probes, wevalidate the pose of the compound and support their substrate competitive MOA by comparing their activity against both strong and weak pre-mRNA substrates. Finally, we present functional data and structure-activity relationship (SAR) on the PHF5A(R38C) mutation that sensitizes cells to some chemical probes but not others. Developing small molecule splicing modulators represents a promising therapeutic approach for a variety of diseases, and this work provides a significant step in enabling structure-based drug design for these elaborate natural products. Importantly, this work also demonstrates that the utilization of cryo-EM in drug discovery is coming of age.

Cryo-EM analyses of dimerized spliceosomes provide new insights into the functions of B complex proteins

Cryo-EM Structure of a Pre-catalytic Human Spliceosome Primed for Activation

Structure and Conformational Dynamics of the Human Spliceosomal Bact Complex

An Atomic Structure of the Human Spliceosome

Structural Insights into the Roles of Metazoan-Specific Splicing Factors in the Human Step 1 Spliceosome

Structural insights into the cross-exon to cross-intron spliceosome switch

Structure of the human activated spliceosome in three conformational states

Structures of the human pre-catalytic spliceosome and its precursor spliceosome

Molecular basis for the activation of human spliceosome

Structural insights into human exon-defined spliceosome prior to activation

Molecular Mechanisms of Pre-Mrna Splicing Through Structural Biology of the Spliceosome.

Dynamic interactions drive early spliceosome assembly

Structures of the Catalytically Activated Yeast Spliceosome Reveal the Mechanism of Branching

The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action.

Mechanism of exon ligation by human spliceosome

Protein localisation by electron microscopy reveals the architecture of the yeast spliceosomal B complex

Cryo-EM structures of Smc5/6 in multiple states reveal its assembly and functional mechanisms

Structures of aberrant spliceosome intermediates on their way to disassembly

Structures of the human spliceosomes before and after release of the ligated exon

Structure of a Human Catalytic Step I Spliceosome.

Mechanistic insights into precursor messenger RNA splicing by the spliceosome